PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Internal Medicine, University of California, San Francisco, Calif.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, Calif.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, Calif; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, Calif; Clinical Microbiology Laboratory, Stanford Health Care, Stanford, Calif.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, Calif; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, Calif; Clinical Virology Laboratory, Stanford Health Care, Stanford, Calif.\', \'Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, Calif.\', \'Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, Calif. Electronic address: yaelg@stanford.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0091-6749(21)02667-110.1016/j.jaci.2021.11.022
?:doi
?:hasPublicationType
?:journal
  • The Journal of allergy and clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 34952033
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all